Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients with Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s632, 2025. DOI: 10.25251/6744kd41. Disponível em: https://skin.dermsquared.com/skin/article/view/3777. Acesso em: 17 apr. 2026.